Kirkland Represents Teva Pharmaceutical Industries on Acquisition of Anda Distribution Business from Allergan for $500 Million

Kirkland & Ellis LLP represents Teva Pharmaceutical Industries Ltd. (TEVA), which announced today that it reached a definitive agreement under which Teva will acquire the Anda distribution business from Allergan plc. Anda is the fourth largest distributor of generic pharmaceuticals in the U.S.  The purchase price is $500 million. More information on the transaction is available here.

The Kirkland team representing Teva was led by corporate partners Daniel Wolf and Michael Brueck.